Glycemic control and hypoglycemia in Asian type 2 diabetes patients treated with insulin glargine plus glimepiride versus NPH insulin plus glimepiride

被引：0

|

作者：

Pan, CY

Bianchi-Biscay, M

Chung, KD

Kim, KW

机构：

来源：

DIABETES | 2004年 / 53卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A488 / A488

页数：1

相关论文

共 50 条

[21] Comparative study to evaluate the effect of L-carnitine plus glimepiride versus glimepiride alone on insulin resistance in type 2 diabetic patients
El-sheikh, Hadier M.
El-Haggar, Sahar M.
Elbedewy, Tamer A.
[J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (01) : 167 - 173
[22] A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting
Cesur, Mustafa
Corapcioglu, Demet
Gursoy, Alptekin
Gonen, Sait
Ozduman, Mine
Emral, Rifat
Uysal, Ali Riza
Tonyukuk, Vedia
Yilmaz, Arif Ender
Bayram, Fahri
Kamel, Nuri
[J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 75 (02) : 141 - 147
[23] Reduced hypoglycemia risk with insulin glargine - A metaanalysis comparing insulin glargine with human NPH insulin in type 2 diabetes
Rosenstock, J
Dailey, G
Massi-Benedetti, M
Fritsche, A
Lin, ZN
Salzman, A
[J]. DIABETES CARE, 2005, 28 (04) : 950 - 955
[24] Impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes treated with insulin glargine or NPH insulin
Dailey, G. E.
Gao, L.
Aurand, L.
Garg, S. K.
[J]. DIABETES OBESITY & METABOLISM, 2013, 15 (12): : 1085 - 1092
[25] Hypoglycemia and glycemic control in type 2 diabetes: a meta-analysis of six randomized controlled trials comparing insulin NPH with insulin glargine
Mullins, Peter
Jarvinen, Hannele Yki
Sharplin, Peter A.
Riddle, Matthew
[J]. DIABETES, 2007, 56 : A160 - A160
[26] Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone
Riddle, MC
Schneider, J
[J]. DIABETES CARE, 1998, 21 (07) : 1052 - 1057
[27] A randomized crossover trial comparing insulin glargine plus insulin lispro with NPH insulin plus soluable insulin in adolescents with Type 1 diabetes.
Murphy, N
Keane, S
Ong, K
Ford-Adams, M
Edge, J
Dunger, D
[J]. DIABETOLOGIA, 2002, 45 : A281 - A281
[28] Confirmed lower risk of hypoglycemia with insulin glargine versus NPH insulin:: A meta-analysis of 2304 patients with type 2 diabetes
Rosenstock, J
Benedetti, MM
Häring, HU
Salzman, A
[J]. DIABETES, 2003, 52 : A454 - A454
[29] Duration of diabetes and hypoglycaemia rates in type 2 diabetes patients treated with insulin glargine vs NPH insulin
Dailey, G.
Aurand, L.
Garg, S.
[J]. DIABETOLOGIA, 2011, 54 : S262 - S262
[30] Impact of Insulin Glargine on Glycemic Control and Hypoglycemia in Patients With Type 1 Diabetes Previously Treated With Other Insulins
Chase, Peter
Lin, Jay
Wei, Wenhui
Cali, Anna
Dailey, George
[J]. DIABETES, 2013, 62 : A650 - A650

← 1 2 3 4 5 →